{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:51:49Z","timestamp":1794001909170,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00392-024-02451-0","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T11:01:32Z","timestamp":1714647692000},"page":"951-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Beta blockers are associated with lower all-cause mortality among HFpEF patients"],"prefix":"10.1007","volume":"113","author":[{"given":"Joseph","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Fabrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floyd","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenden","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh R.","family":"Mulukutla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica H.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-4921","authenticated-orcid":false,"given":"Gavin W.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"issue":"7","key":"2451_CR1","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33(7):1948\u20131955","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2451_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0002-9149(00)01165-6","volume":"86","author":"RB Devereux","year":"2000","unstructured":"Devereux RB, Roman MJ, Liu JE, Welty TK, Lee ET, Rodeheffer R et al (2000) Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 86(10):1090\u20131096","journal-title":"Am J Cardiol"},{"issue":"4","key":"2451_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9149(00)01393-X","volume":"87","author":"DW Kitzman","year":"2001","unstructured":"Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G et al (2001) Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 87(4):413\u20139","journal-title":"Am J Cardiol."},{"key":"2451_CR4","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895\u2013e1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","DOI":"10.1161\/CIR.0000000000001063"},{"issue":"14","key":"2451_CR5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","volume":"25","author":"MJ Lenzen","year":"2004","unstructured":"Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Swedberg K et al (2004) Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25(14):1214\u201320","journal-title":"Eur Heart J"},{"issue":"1","key":"2451_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47(1):76\u201384","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"2451_CR7","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/heartjnl-2021-319605","volume":"108","author":"AB Gevaert","year":"2022","unstructured":"Gevaert AB, Kataria R, Zannad F, Sauer AJ, Damman K, Sharma K et al (2022) Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart 108(17):1342\u20131350","journal-title":"Heart"},{"issue":"19","key":"2451_CR8","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","volume":"27","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27(19):2338\u20132345","journal-title":"Eur Heart J"},{"issue":"23","key":"2451_CR9","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456\u20132467","journal-title":"N Engl J Med"},{"issue":"15","key":"2451_CR10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383\u20131392","journal-title":"N Engl J Med"},{"issue":"17","key":"2451_CR11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP et al (2019) Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609\u20131620","journal-title":"N Engl J Med"},{"issue":"9386","key":"2451_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362(9386):777\u2013781","journal-title":"Lancet"},{"issue":"21","key":"2451_CR13","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334(21):1349\u20131355","journal-title":"N Engl J Med"},{"issue":"9146","key":"2451_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","unstructured":"CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. The Lancet 353(9146):9\u201313","journal-title":"The Lancet"},{"issue":"9169","key":"2451_CR15","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in-congestive heart failure (MERIT-HF). The Lancet 353(9169):2001\u20132007","journal-title":"The Lancet"},{"issue":"1","key":"2451_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","volume":"39","author":"JGF Cleland","year":"2018","unstructured":"Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS et al (2018) Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J 39(1):26\u201335","journal-title":"Eur Heart J"},{"issue":"23","key":"2451_CR17","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","volume":"53","author":"DJ van Veldhuisen","year":"2009","unstructured":"van Veldhuisen DJ, Cohen-Solal A, B\u00f6hm M, Anker SD, Babalis D, Roughton M et al (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 53(23):2150\u20132158","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2451_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.amjhyper.2004.07.007","volume":"17","author":"M Kobayashi","year":"2004","unstructured":"Kobayashi M, Machida N, Mitsuishi M, Yamane Y (2004) \u03b2-Blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Am J Hypertens 17(12):1112\u20131119","journal-title":"Am J Hypertens"},{"issue":"5","key":"2451_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ejheart.2008.03.002","volume":"10","author":"M Nishio","year":"2008","unstructured":"Nishio M, Sakata Y, Mano T, Ohtani T, Takeda Y, Miwa T et al (2008) Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats. Eur J Heart Fail 10(5):446\u2013453","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"2451_CR20","doi-asserted-by":"publisher","first-page":"e1916598","DOI":"10.1001\/jamanetworkopen.2019.16598","volume":"2","author":"DN Silverman","year":"2019","unstructured":"Silverman DN, Plante TB, Infeld M, Callas PW, Juraschek SP, Dougherty GB et al (2019) Association of \u03b2-blocker use with heart failure hospitalizations and cardiovascular disease mortality among patients with heart failure with a preserved ejection fraction: a secondary analysis of the TOPCAT Trial. JAMA Network Open 2(12):e1916598","journal-title":"JAMA Network Open"},{"issue":"11","key":"2451_CR21","first-page":"e007180","volume":"13","author":"EL Fu","year":"2020","unstructured":"Fu EL, Uijl A, Dekker FW, Lund LH, Savarese G, Carrero JJ (2020) Association between & #x3b2;-blocker use and mortality\/morbidity in patients with heart failure with reduced, midrange, and preserved ejection fraction and advanced chronic kidney disease. Circulation: Heart Failure. 13(11):e007180","journal-title":"Circulation: Heart Failure."},{"issue":"21","key":"2451_CR22","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","volume":"78","author":"P Palau","year":"2021","unstructured":"Palau P, Seller J, Dom\u00ednguez E, Sastre C, Ram\u00f3n Jose M, de La Espriella R et al (2021) Effect of \u03b2-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction. J Am Coll Cardiol 78(21):2042\u20132056","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2451_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJM198104023041401","volume":"304","author":"Norwegian Multicenter Study Group","year":"1981","unstructured":"Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304(14):801\u2013807","journal-title":"N Engl J Med"},{"issue":"6 Pt 2","key":"2451_CR24","first-page":"I26","volume":"67","author":"A Hjalmarson","year":"1983","unstructured":"Hjalmarson A, Herlitz J, Holmberg S, Ryd\u00e9n L, Swedberg K, Vedin A et al (1983) The G\u00f6teborg Metoprolol Trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 67(6 Pt 2):I26-32","journal-title":"Circulation"},{"issue":"3","key":"2451_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","volume":"73","author":"K Chadda","year":"1986","unstructured":"Chadda K, Goldstein S, Byington R, Curb JD (1986) Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 73(3):503\u2013510","journal-title":"Circulation"},{"issue":"7200","key":"2451_CR26","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) \u03b2 Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318(7200):1730\u20131737","journal-title":"BMJ"},{"key":"2451_CR27","doi-asserted-by":"publisher","first-page":"757596","DOI":"10.3389\/fcvm.2021.757596","volume":"8","author":"Y He","year":"2021","unstructured":"He Y, Ling Y, Guo W, Li Q, Yu S, Huang H et al (2021) Prevalence and prognosis of HFimpEF developed from patients with heart failure with reduced ejection fraction: systematic review and meta-analysis. Front Cardiovasc Med 8:757596","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"2451_CR28","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/MLR.0000000000001010","volume":"57","author":"AJ Mainor","year":"2019","unstructured":"Mainor AJ, Morden NE, Smith J, Tomlin S, Skinner J (2019) ICD-10 coding will challenge researchers: caution and collaboration may reduce measurement error and improve comparability over time. Med Care 57(7):e42\u2013e46","journal-title":"Med Care"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-024-02451-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T03:06:22Z","timestamp":1716260782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-024-02451-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2451"],"URL":"https:\/\/doi.org\/10.1007\/s00392-024-02451-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Suresh R. Mulukutla: Medtronic Advisory Board, Amgen Funding for QI Project, Novartis Funding to participate in CardioHealth Alliance. Marc A. Simon: Consultant for Actelion\/Janssen, ImpulseDynamics, Liquidia, Bayer. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}